{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:21:56Z","timestamp":1790634116862,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in creatine (Cr) transporter (CrT) gene lead to cerebral creatine deficiency syndrome-1 (CTD), an orphan neurodevelopmental disorder presenting with brain Cr deficiency, intellectual disability, seizures, movement and autistic-like behavioral disturbances, language and speech impairment. We have recently generated a murine model of CTD obtained by ubiquitous deletion of 5\u20137 exons in the CrT gene. These mice showed a marked Cr depletion, associated to early and progressive cognitive\u00a0impairment, and autistic-like defects, thus resembling the key features of human CTD. Given the importance of extraneural dysfunctions in neurodevelopmental disorders, here we analyzed the specific role of neural Cr in the CTD phenotype. We induced the conditional deletion of <jats:italic>Slc6a8<\/jats:italic> gene in neuronal and glial cells by crossing CrT floxed mice with the Nestin::Cre recombinase Tg (Nes-cre) 1Kln mouse. We report that nervous system-specific Cr depletion leads to a progressive cognitive regression starting in the adult age. No autistic-like features, including repetitive and stereotyped movements, routines and rituals, are present in this model. These results indicate that Cr depletion in the nervous system is a pivotal cause of the CTD pathological phenotype, in particular with regard to the cognitive domain, but extraneural actors also play a role.<\/jats:p>","DOI":"10.1038\/s41598-018-37303-1","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T15:04:06Z","timestamp":1546959846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Nervous System-Specific Model of Creatine Transporter Deficiency Recapitulates the Cognitive Endophenotype of the Disease: a Longitudinal Study"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-4429","authenticated-orcid":false,"given":"Angelo","family":"Molinaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3467-8648","authenticated-orcid":false,"given":"Maria Grazia","family":"Alessandr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Putignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-6139","authenticated-orcid":false,"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-5566","authenticated-orcid":false,"given":"Giovanni","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-2860","authenticated-orcid":false,"given":"Laura","family":"Baroncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5614-0668","authenticated-orcid":false,"given":"Tommaso","family":"Pizzorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"37303_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10545-014-9713-8","volume":"37","author":"JM van de Kamp","year":"2014","unstructured":"van de Kamp, J. M., Mancini, G. M. & Salomons, G. S. X-linked creatine transporter deficiency: clinical aspects and pathophysiology. J. Inherit. Metab. Dis. 37, 715\u2013733 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"37303_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biochi.2015.10.022","volume":"119","author":"M Joncquel-Chevalier Curt","year":"2015","unstructured":"Joncquel-Chevalier Curt, M. et al. Creatine biosynthesis and transport in health and disease. Biochimie 119, 146\u2013165 (2015).","journal-title":"Biochimie"},{"key":"37303_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(96)04116-5","volume":"348","author":"S St\u00f6ckler","year":"1996","unstructured":"St\u00f6ckler, S., Hanefeld, F. & Frahm, J. Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348, 789\u2013790 (1996).","journal-title":"Lancet"},{"key":"37303_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1006\/mgme.2001.3257","volume":"74","author":"A Schulze","year":"2001","unstructured":"Schulze, A., Ebinger, F., Rating, D. & Mayatepek, E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol. Genet. Metab. 74, 413\u2013419 (2001).","journal-title":"Mol. Genet. Metab."},{"key":"37303_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1096-7192(02)00175-0","volume":"77","author":"R Battini","year":"2002","unstructured":"Battini, R. et al. Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol. Genet. Metab. 77, 326\u2013331 (2002).","journal-title":"Mol. Genet. Metab."},{"key":"37303_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/13554790802060821","volume":"14","author":"A Chilosi","year":"2008","unstructured":"Chilosi, A. et al. Treatment withl-Arginine improves neuropsychological disorders in a child with Creatine transporter defect. Neurocase 14, 151\u2013161 (2008).","journal-title":"Neurocase"},{"key":"37303_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ymgme.2010.08.016","volume":"101","author":"S Mercimek-Mahmutoglu","year":"2010","unstructured":"Mercimek-Mahmutoglu, S. et al. Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol. Genet. Metab. 101, 409\u2013412 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"37303_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10545-011-9358-9","volume":"35","author":"V Valayannopoulos","year":"2012","unstructured":"Valayannopoulos, V. et al. Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J. Inherit. Metab. Dis. 35, 151\u2013157 (2012).","journal-title":"J. Inherit. Metab. Dis."},{"key":"37303_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2014.05.011","volume":"112","author":"M Dunbar","year":"2014","unstructured":"Dunbar, M., Jaggumantri, S., Sargent, M., Stockler-Ipsiroglu, S. & van Karnebeek, C. D. M. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases. Mol. Genet. Metab. 112, 259\u2013274 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"37303_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pediatrneurol.2015.05.006","volume":"53","author":"S Jaggumantri","year":"2015","unstructured":"Jaggumantri, S. et al. Treatment of Creatine Transporter (SLC6A8) Deficiency With Oral S-Adenosyl Methionine as Adjunct to L-arginine, Glycine, and Creatine. Supplements. Pediatr. Neurol. 53, 360\u2013363.e2 (2015).","journal-title":"Supplements. Pediatr. Neurol."},{"key":"37303_CR11","doi-asserted-by":"publisher","first-page":"e16187","DOI":"10.1371\/journal.pone.0016187","volume":"6","author":"MR Skelton","year":"2011","unstructured":"Skelton, M. R. et al. Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS One 6, e16187 (2011).","journal-title":"PLoS One"},{"key":"37303_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12688\/f1000research.5369.1","volume":"3","author":"L Baroncelli","year":"2014","unstructured":"Baroncelli, L. et al. A novel mouse model of creatine transporter deficiency. F1000Res. 3, 228 (2014).","journal-title":"F1000Res."},{"key":"37303_CR13","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1172\/JCI59373","volume":"122","author":"Y Kurosawa","year":"2012","unstructured":"Kurosawa, Y. et al. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. J. Clin. Invest. 122, 2837\u20132846 (2012).","journal-title":"J. Clin. Invest."},{"key":"37303_CR14","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1093\/hmg\/ddw252","volume":"25","author":"L Baroncelli","year":"2016","unstructured":"Baroncelli, L. et al. A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging. Hum. Mol. Genet. 25, 4186\u20134200 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"37303_CR15","doi-asserted-by":"publisher","first-page":"e12461","DOI":"10.1111\/gbb.12461","volume":"17","author":"KC Udobi","year":"2018","unstructured":"Udobi, K. C. et al. Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8. Genes Brain Behav. 17, e12461 (2018).","journal-title":"Genes Brain Behav."},{"key":"37303_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mcn.2012.10.003","volume":"53","author":"AM Depino","year":"2013","unstructured":"Depino, A. M. Peripheral and central inflammation in autism spectrum disorders. Mol. Cell. Neurosci. 53, 69\u201376 (2013).","journal-title":"Mol. Cell. Neurosci."},{"key":"37303_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13416","volume":"1420","author":"E Sherwin","year":"2017","unstructured":"Sherwin, E., Dinan, T. G. & Cryan, J. F. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann. N. Y. Acad. Sci. 1420, 5\u201325 (2017).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"37303_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/12703","volume":"23","author":"F Tronche","year":"1999","unstructured":"Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99\u2013103 (1999).","journal-title":"Nat. Genet."},{"key":"37303_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpsychires.2014.04.002","volume":"55","author":"SA Giusti","year":"2014","unstructured":"Giusti, S. A. et al. Behavioral phenotyping of Nestin-Cre mice: implications for genetic mouse models of psychiatric disorders. J. Psychiatr. Res. 55, 87\u201395 (2014).","journal-title":"J. Psychiatr. Res."},{"key":"37303_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cell.2014.04.045","volume":"158","author":"PE Rothwell","year":"2014","unstructured":"Rothwell, P. E. et al. Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors. Cell 158, 198\u2013212 (2014).","journal-title":"Cell"},{"key":"37303_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnins.2016.00027","volume":"10","author":"MV Fuccillo","year":"2016","unstructured":"Fuccillo, M. V. Striatal Circuits as a Common Node for AutismPathophysiology. Front. Neurosci. 10, 27 (2016).","journal-title":"Front. Neurosci."},{"key":"37303_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10545-013-9619-x","volume":"37","author":"ER Hautman","year":"2014","unstructured":"Hautman, E. R. et al. Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits. J Inherit Metab Dis. 37, 63\u201368 (2014).","journal-title":"J Inherit Metab Dis."},{"key":"37303_CR23","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1096\/fj.12-225136","volume":"27","author":"M Stockebrand","year":"2013","unstructured":"Stockebrand, M., Sauter, K., Neu, A., Isbrandt, D. & Choe, C.-U. Differential regulation of AMPK activation in leptin- and creatine-deficient mice. FASEB J. 27, 4147\u20134156 (2013).","journal-title":"FASEB J."},{"key":"37303_CR24","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00726-016-2291-3","volume":"48","author":"MK Perna","year":"2016","unstructured":"Perna, M. K. et al. Creatine transporter deficiency leads to increased whole body and cellular metabolism. Amino Acids 48, 2057\u20132065 (2016).","journal-title":"Amino Acids"},{"key":"37303_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10545-011-9345-1","volume":"35","author":"JM van de Kamp","year":"2012","unstructured":"van de Kamp, J. M. et al. Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J. Inherit. Metab. Dis. 35, 141\u2013149 (2012).","journal-title":"J. Inherit. Metab. Dis."},{"key":"37303_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/A:1022487218904","volume":"244","author":"TJ deGrauw","year":"2003","unstructured":"deGrauw, T. J. et al. The clinical syndrome of creatine transporter deficiency. Mol. Cell. Biochem. 244, 45\u201348 (2003).","journal-title":"Mol. Cell. Biochem."},{"key":"37303_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/B:MCBI.0000038213.15646.4a","volume":"262","author":"GJ Pyne-Geithman","year":"2004","unstructured":"Pyne-Geithman, G. J. et al. Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study. Mol. Cell. Biochem. 262, 35\u201339 (2004).","journal-title":"Mol. Cell. Biochem."},{"key":"37303_CR28","doi-asserted-by":"publisher","first-page":"23539","DOI":"10.18632\/oncotarget.15328","volume":"8","author":"E Vannini","year":"2017","unstructured":"Vannini, E. et al. Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages. Oncotarget 8, 23539\u201323550 (2017).","journal-title":"Oncotarget"},{"key":"37303_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ab.2005.05.003","volume":"343","author":"MG Alessandr\u00ec","year":"2005","unstructured":"Alessandr\u00ec, M. G., Celati, L., Battini, R., Casarano, M. & Cioni, G. Gas chromatography\/mass spectrometry assay for arginine: glycine-amidinotransferase deficiency. Anal. Biochem. 343, 356\u2013358 (2005).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37303-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37303-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37303-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:44:40Z","timestamp":1671252280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37303-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37303"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37303-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"62"}}